Pharmacotherapy of cystic fibrosis: inhaled antibiotics
Respiratory infection in cystic fibrosis develops in the first years of life and plays a key role in shaping the prognosis of the disease. Microbiology of respiratory infection in such patients is significantly different from that in patients without cystic fibrosis. Adequate antibiotic therapy with...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Remedium Group LLC
2013-12-01
|
| Series: | Медицинский совет |
| Subjects: | |
| Online Access: | https://www.med-sovet.pro/jour/article/view/1149 |
| _version_ | 1797841286946881536 |
|---|---|
| author | N. I. Kapranov |
| author_facet | N. I. Kapranov |
| author_sort | N. I. Kapranov |
| collection | DOAJ |
| description | Respiratory infection in cystic fibrosis develops in the first years of life and plays a key role in shaping the prognosis of the disease. Microbiology of respiratory infection in such patients is significantly different from that in patients without cystic fibrosis. Adequate antibiotic therapy with inhaled drugs can delay and sometimes even prevent the onset of chronic Pseudomonas aeruginosa infection, while significantly extending the years of qualitative life of patients with cystic fibrosis. |
| first_indexed | 2024-04-09T16:28:33Z |
| format | Article |
| id | doaj.art-60775db72cca4f9d8c1cca7d2de14d87 |
| institution | Directory Open Access Journal |
| issn | 2079-701X 2658-5790 |
| language | Russian |
| last_indexed | 2024-04-09T16:28:33Z |
| publishDate | 2013-12-01 |
| publisher | Remedium Group LLC |
| record_format | Article |
| series | Медицинский совет |
| spelling | doaj.art-60775db72cca4f9d8c1cca7d2de14d872023-04-23T06:57:13ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902013-12-01011626910.21518/2079-701X-2013-11-62-691149Pharmacotherapy of cystic fibrosis: inhaled antibioticsN. I. Kapranov0Research Centre of Medical Genetics of RAMSRespiratory infection in cystic fibrosis develops in the first years of life and plays a key role in shaping the prognosis of the disease. Microbiology of respiratory infection in such patients is significantly different from that in patients without cystic fibrosis. Adequate antibiotic therapy with inhaled drugs can delay and sometimes even prevent the onset of chronic Pseudomonas aeruginosa infection, while significantly extending the years of qualitative life of patients with cystic fibrosis.https://www.med-sovet.pro/jour/article/view/1149муковисцидознеонатальный скринингхроническая инфекцияингаляционная антибиотикотерапиябрамитобcystic fibrosisnewborn screeningchronic infectioninhaled antibiotic therapybramitob |
| spellingShingle | N. I. Kapranov Pharmacotherapy of cystic fibrosis: inhaled antibiotics Медицинский совет муковисцидоз неонатальный скрининг хроническая инфекция ингаляционная антибиотикотерапия брамитоб cystic fibrosis newborn screening chronic infection inhaled antibiotic therapy bramitob |
| title | Pharmacotherapy of cystic fibrosis: inhaled antibiotics |
| title_full | Pharmacotherapy of cystic fibrosis: inhaled antibiotics |
| title_fullStr | Pharmacotherapy of cystic fibrosis: inhaled antibiotics |
| title_full_unstemmed | Pharmacotherapy of cystic fibrosis: inhaled antibiotics |
| title_short | Pharmacotherapy of cystic fibrosis: inhaled antibiotics |
| title_sort | pharmacotherapy of cystic fibrosis inhaled antibiotics |
| topic | муковисцидоз неонатальный скрининг хроническая инфекция ингаляционная антибиотикотерапия брамитоб cystic fibrosis newborn screening chronic infection inhaled antibiotic therapy bramitob |
| url | https://www.med-sovet.pro/jour/article/view/1149 |
| work_keys_str_mv | AT nikapranov pharmacotherapyofcysticfibrosisinhaledantibiotics |